Bausch Health Companies Inc.
Cash Flow Statement
| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $436.0M | $258.0M | $-1.42B | $-112.0M | $179.0M | $148.0M | $-58.0M | $93.0M |
| Depreciation & Amortization | $284.0M | $281.0M | $295.0M | $290.0M | $306.0M | $307.0M | $305.0M | $307.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $52.0M | $54.0M | $52.0M | $84.0M | $43.0M | $46.0M | $43.0M | $43.0M |
| Net Cash from Operating Activities | $814.0M | $670.0M | $230.0M | $495.0M | $405.0M | $289.0M | $211.0M | $601.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $66.0M | $77.0M | $109.0M | $92.0M | $91.0M | $99.0M | $115.0M | $106.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-83.0M | $-93.0M | $-139.0M | $-282.0M | $-83.0M | $-100.0M | $-130.0M | $-200.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-80.0M | $-49.0M | $-100.0M | $-235.0M | $-719.0M | $358.0M | $-146.0M | $85.0M |
| Net Change in Cash | $650.0M | $526.0M | $-13.0M | $-15.0M | $-403.0M | $586.0M | $-44.0M | $451.0M |
| Free Cash Flow | $748.0M | $593.0M | $121.0M | $403.0M | $314.0M | $190.0M | $96.0M | $495.0M |